老年急性冠脉综合征患者支架植入后应用高维持量氯吡格雷的疗效观察
被引量:1
摘要
随着药物洗脱支架(DES)植入增多,术后支架内血栓等事件也相应增加,因此需要更加积极抗血小板治疗以减少主要不良心脏事件。经皮冠状动脉介入治疗(PCI)围手术期给以高维持剂量氯吡格雷可以改善植入支架的ACS患者的临床预后,但高维持剂量氯吡格雷在老年患者应用是否同样安全,相关研究不多。本研究旨在评价300mg负荷量加,
出处
《中国现代医药杂志》
2012年第9期97-98,共2页
Modern Medicine Journal of China
参考文献4
-
1Kushner FG, Hand M, Smith SC Jr,et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-el-evation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. J Am Coll Cardiol, 2009,54 (23) : 2205 -2241.
-
2Nguyen TA,Lordkipanidz6 M,Diodati JG,et al. Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention : results of a double-blind,randomized clinical trial[J]. 2009,22(4) :368-377.
-
3蔡国才,周鹏,张磊,王秋林,雷长城,曾高峰,匡希斌.冠状动脉植入药物支架术后高维持剂量氯吡格雷治疗的近期疗效[J].心脏杂志,2010,22(3):396-400. 被引量:3
-
4Lemesle G, Delhaye C, Sudre A, et al. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome [J]. Am Heart J,2009,157(2) :375-382.
二级参考文献14
-
1Mehta SR, Yusuf S, Peters R J, et al. Effects of pretreament with elopidogrel and aspirin followed by long-tern therapy in patients under-going pereutaneous coronary intervention the PCI-CURE, study [J]. Lancet, 2001, 358(9281):527-533.
-
2Steinhubl SR, Berger PB, Maim JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention a randonized controlled trial[ J]. JAMA, 2002, 288 (19) : 2411 - 2420.
-
3Cuisset T, Frere C, Quilici J, et al. High post-treament platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute syndrome[J]. J Thromb Haemost, 2006, 4 (3) :542 - 549.
-
4Frere C, Cuisset T, Quilici J, et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome [ J]. Thromb Haemost, 2007, 98 (4) :838 - 843.
-
5Sibbing D, yon Beckerath O, Schomig A, et al. Platelet function in clopidogrel-treated patients with acute coronary syndrome[J]. Blood Coagul Fibrinolysis, 2007, 18(4) :335 -339.
-
6Matekt A, Spiewak M, Filipiak KJ, et al. Persistent platelet activation is related to very early Cardiovascular events in patients with acute coronary syndromes[ J]. Kardiol Pol, 2007, 65(1) :40-45.
-
7Cuisset T, Frere C, Quilici J, et al. High post-treament platelet reactivity is associated with a high incidence of myoneciosis after stenting for non-ST elevation acute coronary syndromes[ J ]. Thromb Haemost, 2007, 97 (2) : 282 - 287.
-
8von-Beckerath N, Kastrati A, Wieczorek A, et al. A double-blind randanized study on platelet aggregation in patients treated w ith a daily dose of 150 or 75 mg of clopidogrel for 30 days[ J]. Eur Heart J, 2007, 28(15):1814-1819.
-
9Mitsios JV, Papathanasiou AI, Elisaf M, et al. The inhibitory potency of elopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes [ J ]. Platelets, 2005, 16(5) :287 -292.
-
10Tetik S, Uras F, Eksiog lu-Demiralp E, et al. Low-Denssity lipoprotein specifically binds glyeoprotein II b/IIIa: a flow cytometrie method for lignld-receptor interaction [ J ]. Clin Appl Thromb Hemost, 2007, 26(23):143- 154.
同被引文献3
-
1尤家聪.强化抗血小板治疗对PCI术后QT离散度的影响[J].现代仪器与医疗,2013,19(4):53-55. 被引量:7
-
2郭亮,高远,张海山,关启刚,田文,贾大林,孙英贤.强化他汀治疗对急性冠脉综合征行介入治疗患者的疗效与安全性[J].中国循证心血管医学杂志,2013,5(4):377-379. 被引量:16
-
3邹琪,曹霞,李莎恩.瑞舒伐他汀钙对急性冠脉综合症患者PCI术后IL-18、hs-CRP影响[J].现代仪器与医疗,2014,20(2):76-78. 被引量:21
-
1赵森.瑞替普酶与rt-PA对急性ST段抬高型心肌梗死老年患者的溶栓效果对比分析[J].中国医学工程,2013,21(9):40-40. 被引量:1
-
2李乐春,周斌,程冰湖.老年患者应用小剂量哌替啶致猝死二例[J].临床误诊误治,2008,21(1):91-91.
-
3洪原城,黄种杰,黄鑫成,范洪涛.稳定期COPD并冠心病老年患者应用噻托溴铵治疗的临床研究[J].临床肺科杂志,2012,17(12):2174-2176. 被引量:7
-
4张玲玲.低分子肝素对老年不稳定型心绞痛患者的疗效分析[J].医学信息(下旬刊),2009(7):51-52.
-
5焦其英.慢性呼吸衰竭老年患者应用无创正压通气的护理[J].中国误诊学杂志,2008,8(20):4980-4981.
-
6王德伟,黄洁,杨海英.冠心病合并糖尿病老年患者冠脉药物洗脱支架再狭窄的相关因素分析[J].河北中医,2014,36(8):1261-1264. 被引量:4
-
7杜煜,刘丽娟.急性ST段抬高型心肌梗死老年患者主动脉内球囊反搏后血小板减少2例[J].中国医药科学,2013,3(12):170-171.
-
8王雅萍.卡托普利与缬沙坦治疗老年慢性心力衰竭的临床对比[J].中国医刊,2009,44(2):40-41. 被引量:3
-
9王玉红,刘晖,何伟明.依那普利与厄贝沙坦治疗老年慢性心力衰竭的临床比较[J].中国实用医药,2016,11(11):125-126. 被引量:1
-
10朱德生,傅珏.奥美拉唑预防老年人应激性溃疡出血临床疗效[J].老年医学与保健,2004,10(1):54-55. 被引量:3